{
  "Ticker": "AMGN",
  "Summary": "Amgen (AMGN) analyzed 6 bills; no direct or indirect impacts identified. Overall risk assessment: negligible. Legislative activity poses minimal threat to operations or financial outlook.",
  "SummaryKeypoints": [
    "No significant law impacts identified"
  ],
  "DirectRiskFactor": 0,
  "IndirectRiskFactor": 0,
  "TimeFactor": 0.75
}